Cargando…

COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence

Detalles Bibliográficos
Autores principales:	Venerito, Vincenzo, Lopalco, Giuseppe, Iannone, Florenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103910/ https://www.ncbi.nlm.nih.gov/pubmed/32232551 http://dx.doi.org/10.1007/s00296-020-04566-9

Ejemplares similares

Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis
por: Cacciapaglia, Fabio, et al.
Publicado: (2022)

Update on the Medical Management of Gastrointestinal Behçet's Disease
por: Lopalco, Giuseppe, et al.
Publicado: (2017)

A Machine Learning Approach to Predict Remission in Patients With Psoriatic Arthritis on Treatment With Secukinumab
por: Venerito, Vincenzo, et al.
Publicado: (2022)

Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study
por: Venerito, Vincenzo, et al.
Publicado: (2023)

Cytokine Signatures in Mucocutaneous and Ocular Behçet’s Disease
por: Lopalco, Giuseppe, et al.
Publicado: (2017)

Exploring the Oral Microbiome in Rheumatic Diseases, State of Art and Future Prospective in Personalized Medicine with an AI Approach
por: Bellando-Randone, Silvia, et al.
Publicado: (2021)

Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors
por: Venerito, Vincenzo, et al.
Publicado: (2022)

Medical College Centenary Celebrations Appeal
por: De, M. N.
Publicado: (1934)

An Appeal
por: Mehta, Chamanlal M.
Publicado: (1950)

An Appeal
por: Parry, B. Gambier
Publicado: (1922)

Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors
por: Barone, Michele, et al.
Publicado: (2018)

Uncovering the Underworld of Axial Spondyloarthritis
por: Del Vescovo, Sergio, et al.
Publicado: (2023)

Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs
por: Georgiev, Tsvetoslav
Publicado: (2020)

Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study
por: Rotondo, Cinzia, et al.
Publicado: (2021)

Management of Takayasu arteritis diagnosed during pregnancy: A case report
por: AREZZO, Francesca, et al.
Publicado: (2020)

AI am a rheumatologist: a practical primer to large language models for rheumatologists
por: Venerito, Vincenzo, et al.
Publicado: (2023)

Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study
por: Venerito, Vincenzo, et al.
Publicado: (2023)

An Appeal
por: Harvey, Robert
Publicado: (1894)

An Appeal to Our Countrymen
por: Banerji, Chaturanan
Publicado: (1896)

An Appeal for Bed-Bugs
por: Patton, W. S.
Publicado: (1906)

An Appeal against the Banishment of Sags
por: Jennings, E.
Publicado: (1900)

Incident systemic rheumatic disease following COVID-19
por: Hsu, Tiffany Y-T, et al.
Publicado: (2021)

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases
por: Bettiol, Alessandra, et al.
Publicado: (2019)

Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk
por: Novelli, Lucia, et al.
Publicado: (2021)

COVID-19 in rheumatic disease patients on immunosuppressive agents
por: Sharmeen, Saika, et al.
Publicado: (2020)

Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic
por: Masini, Francesco, et al.
Publicado: (2020)

Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic
por: Kim, Hyun-Sook, et al.
Publicado: (2020)

The association between immunosuppressant and the outcome of COVID-19
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease
por: Lopalco, Giuseppe, et al.
Publicado: (2015)

Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians
por: Schreiber, Karen, et al.
Publicado: (2020)

Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective
por: Tariq, Javeria, et al.
Publicado: (2021)

Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of Disease
por: Cattalini, Marco, et al.
Publicado: (2015)

Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
por: Barbhaiya, Medha, et al.
Publicado: (2022)

Prevalence of Rheumatic Heart Disease
por: Ceylan, Özben, et al.
Publicado: (2017)

Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease
por: Kow, Chia Siang, et al.
Publicado: (2020)

Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic
por: Mukusheva, Zaure, et al.
Publicado: (2020)

Rheumatism
por: Banerjee, R. P.
Publicado: (1907)

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
por: Ritchie, Andrew I, et al.
Publicado: (2020)

Appeal for Funds to Build a Hostel for Indians in Connection with the Pasteur Institute of India, at Kasauli
por: Lamb, George
Publicado: (1908)

Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives
por: Rotondo, Cinzia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l1h306qrb4igos6aic0tkgnt3n